NOR (ASX) General Comments

Originally posted by Cotchy: ↑

They know the $ is extremely close, that's why they post average 8 downramps per day, LOL!
Whether it's this week, or very soon after, it will set the price off for good.
Re-rate is coming, and the trolls know it.
I doubt anyone believes anything the pathological liar posts (floods the thread with), and I doubt holders other than Tooheys and looney bin get sucked in to it.. but, the more that have sold prior to tier 1 contracts, the better.
All the pieces are coming together.
The PL has been wrong about absolutely everything, and so frequently caught lying, manipulating and posting misinformation - going as far as editing and modifying quotes and figures. It's as low and fraudulent as it gets.
You know the trolls are desperate when they incorrectly post CR almost daily since they sold at the covid lows.
It's like they think holders aren't aware the company has been fully backed by directors/big players for years, since their exit!!
It infuriates them that it's been years since any raise that wasn't at market prices to the directors and players they despise for their losses, who stand to clean up big $.
The PL claims directors exercising options is a CR, Noraaa holders exercising a CR, Tarrant making funds available (preventing dilution or CR) is a CR, LOL.

It's obvious they are doing everything to prevent dilution, keeping as much of the tightly held company to themselves as they can.. and it's great for holders.
Look what happened to his CYM, what a doozy that shambles was. THAT'S A CR!
Price crashes well in excess of 50% from his and Khaki's buy in (after the huge mistake selling nor at lows) suspends almost a year because they can't get finance, dilutes the **** out of it, 75% gone! Worst dilution I've ever seen.
The while time they were suspended, he's daily posting it will happen to Nor!
Meanwhile, Nor SP increases for 2 years, with much more coming.

All the trolls here take out their anger on Nor, to make them feel better about their held disasters like CYM, KFM, UNT, BRK, WWI, MAY.
All shockers, all held by the daily trolls
They only troll Nor though.
Hammer is here because disco posted something absolutely correct on May.
We except the daily g trolling, because nor hurt him and his super so bad.. but, hammer has become 1 of those people, trolling Nor because May had a major failure that could be the end

Expand

‘This week, or very soon after…’

Are you serious, you've been preaching, ad nauseam, since the quarterly that there would be a deal by the end of THIS quarter! Clearly stated I think you said. All in YOUR OPINION (Looked like a carrot dangling to ‘everyone’ else - IMO).

Interested to know what Discovery4 ‘correctly’ posted on MAY? That it was a duster? Erm….

GL with your holding, hopefully for your sake there is a deal this week….or soon after.

No.	Vol.	Price($)
1	100000	4.4¢

No.

Vol.

Price($)

100000

4.4¢

Price($)	Vol.	No.
4.8¢	61185	1

Price($)

Vol.

No.

4.8¢

61185

No.	Vol.	Price($)
1	100000	0.044
2	169999	0.043
1	13888	0.041
2	475000	0.040
1	75000	0.039

No.

Vol.

Price($)

100000

0.044

169999

0.043

13888

0.041

475000

0.040

75000

0.039

Price($)	Vol.	No.
0.048	61185	1
0.049	49000	1
0.050	520000	3
0.056	60000	1
0.058	100000	1

Price($)

Vol.

No.

0.048

61185

0.049

49000

0.050

520000

0.056

60000

0.058

100000

(20min delay)
Last 4.5¢		Change -0.002(4.26%)		Mkt cap ! $21.37M

Open	High	Low	Value	Volume
4.5¢	4.5¢	4.5¢	$225	5K

General Comments, page-8320

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

General Comments, page-8320

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News